NURO News and Press, NeuroMetrix Inc. From 01/22/20

WOBURN, Mass., Jan. 22, 2020 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq:NURO) today announced the shift of its 2019 financial conference call to Monday, January 27, 2020 at 8:00am Eastern Time. Internal scheduling conflicts caused the delay of two business days. The Company apologized fo...

WOBURN, Mass., Jan. 17, 2020 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq:NURO) announced today that it plans to issue its 2019 fourth quarter and full year financial results before the opening of the market on Thursday, January 23, 2020. The Company will host a conference call at 8:00 a.m...

Neovasc (NASDAQ: NVCN ) +121%   files U.S. application for Reducer. More news on: Neovasc Inc., FuelCell Energy, Inc., Sol-Gel Technologies Ltd., Stocks on the move, Read more ...

NeuroMetrix ( NURO +10.8% ) announced  one-for-ten reverse split of its common stock. The shares underlying the Company's outstanding options and warrants will also be adjusted accordingly. More news on: NeuroMetrix, Inc., Healthcare stocks news, Read more ...

WOBURN, Mass., Nov. 18, 2019 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (NASDAQ:NURO) today announced the effectiveness of a one-for-ten reverse split of its common stock. The shares underlying the Company's outstanding options and warrants will also be adjusted accordingly. The reverse stock...

NeuroMetrix, Inc. (NURO) Q3 2019 Earnings Conference Call October 17, 2019, 8:00 am ET Company Participants Thomas Higgins - SVP & CFO Shai Gozani - President & CEO Conference Call Participants Jared Cohen - JM Cowen & Company Presentation Operator Good ...

WOBURN, Mass., Oct. 17, 2019 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today reported financial and business highlights for the quarter ended September 30, 2019. The Company develops and commercializes products for the chronic pain and diabetes markets that utilize neurostimul...

WOBURN, Mass., Oct. 15, 2019 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq:NURO), a health technology company that develops and commercializes products for the chronic pain and diabetes markets, today announced important updates to its Quell ® 2.0 commercial strategy.  This ...

WOBURN, Mass., Oct. 10, 2019 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq:NURO) announced today that it plans to issue its 2019 third quarter financial results before the opening of the market on Thursday, October 17, 2019. The Company will host a conference call at 8:00 a.m., Eastern Time...

NeuroMetrix, Inc. (NURO) Q2 2019 Results Earnings Conference Call July 18, 2019 08:00 AM ET Company Participants Thomas Higgins - SVP, CFO & Treasurer Shai Gozani - Founder, Chairman, CEO, President & Secretary Presentation Operator Good morning, and welcome to...